資源描述：
《胸積液《肺癌合并胸腔積液214例臨床分析》》由會員上傳分享，免費在線閱讀，更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫。
1、JournalofMedicalForumVol.27No.10May2006·21·肺癌合并胸腔積液214例臨床分析楊鈺賢陳志明江藝邱希輝林丹霞汕頭大學(xué)醫(yī)學(xué)院附屬腫瘤醫(yī)院腫瘤內(nèi)科汕頭市515031摘要目的探討肺癌合并胸腔積液的特點,以提高其診斷率。方法對我院近6年來住院的有病理學(xué)確診的214例肺癌合并胸腔積液病例的臨床資料回顧性分析。結(jié)果214例肺癌合并胸腔積液占同期肺癌病例的24.0%;45歲以上(含45歲)180例(84.1%)。主要癥狀為胸悶、氣喘、咳嗽、胸痛、咯血,發(fā)生率在67.3%～31.3%;胸水滲出液203例(94.9%),漏
2、出液11例(5.1%);血性胸液166例(77.6%),非血性48例(22.4%);右側(cè)胸液119例(55.6%),左側(cè)胸液74例(34.6%),雙側(cè)胸液21例(9.8%);大量胸腔積液98例,中量75例,少量41例;腺癌126例(58.9%),鱗癌60例(28.0%),小細胞癌9例(4.2%),大細胞癌10例(4.7%),其它病理類型9例(4.2%);而其中能從胸液中找到癌細胞的有167例(78.0%)。結(jié)論對胸腔積液患者進行全面檢查,分析肺癌致胸腔積液的特點,可提高肺癌的診斷率,縮短確診時間。關(guān)鍵詞肺癌胸腔積液診斷中圖分類號:R734.2
3、文獻標(biāo)識碼:B文章編號:1672-3422(2006)10-0021-03ClinicalAnalysisof214CasesofMalignantPleuralEffusionwithLungCancerYANGYuxian,CHENZhiming,JIANGYi,etalDepartmentofChemotherapy,TumorHospital,ShantouUniversityMedicalCollege,Shantou515031,ChinaABSTRACTObjectiveToinvestigatethecharacteristi
4、csofmalignantpleuraleffusionwithlungcancer,toraisediagnosisrateofmalignantpleuraleffusionwithlungcancer.MethodsToana-lyzeretrospectiveyclinicaldataof214casesoflungcancercomplicatedwithmalignantpleuraleffusionwhohadbeendiagnosedexplicitlybythepathologyinourhospitalinthelast6
5、years.Results214casesofthelungcancercomplicatedwithmalignantpleuraleffusionoccupied24.0%ofalllungcancerinthesameperiod.Patientswhoover45yearsofage(include45yearsold)were180cases(84.1%).Mainsymptomsofcaseswerechestdistress,asthma,cough,chestpainandhemoptysis,occurrenceratefr
6、om67.3%to31.3%.Casesofexudativehydropswere203(94.9%),11casesoftransdatorydropsy(5.1%).Casesofbloodeffusionwere166(77.6%),48casesofnon-bloodeffusion(22.4%).Casesofpleuraleffusionintherightchestwere119(55.6%),74casesoftheleftchest(34.6%),bothchest'swere21cases(9.8%).Casesofag
7、reatdealofpleuraleffusionwere98ca-ses,75casesofmediumquantityofpleuraleffusion,41casesofalittleamountofpleuraleffusion.Casesofadenocarcinomawere126(58.9%),60casesofspuamouscarcinoma(28.0%),9casesofsmallcellcarcinoma(4.2%).10casesoflargecellcarcinoma(4.7%),9casesoftheotherpa
8、tho-logictypes(4.2%),Amongthemfoundoutcarcinomacellfromthepleuraleffusionwere167ca
